Publications | Resources

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

Title

Author

Year

Long-Acting HIV Therapy in African Adults with Adherence Challenges.

CRESSWELL, FV; KITONSA, J; Norcross, C; Tumusiime, V; Ombajo, LA; Garrett, N; Kassim, S; Owarwo, NC; Laker Odongpiny, EA; Yawe, I; Mahomed, S; Mugerwa, H; Kafeero, PL; Nkuranga, J; BAHEMUKA, U; Nabbuto, J; Ankunda, V; Nabaggala, P; Ogwang, C; Kimbugwe, G; KAKANDE, A; Singh, U; Van der Vendt, D; Onyango, A; Koile, E; ... IMPALA Study Group,

2026

New England Journal of Medicine, (2026).395 15 10.1056/NEJMoa2518753.

Adaptation and Evaluation of a Multi-Component School-Based Sexual Reproductive Health Intervention Safer Choices Programme in Rural KwaZulu-Natal, South Africa - A Process Evaluation.

Chimbindi, N; Ngema, U; SEELEY, J; Gibbs, A; Harrison, A; Davies, A; Baral, S; Elwy, AR; Shahmanesh, M;

2026

Journal of the International AIDS Society, (2026).29 Sup Suppl 10.1002/jia2.70192.

A systematic review of evidence on weight change following initiation of long-acting cabotegravir for the prevention or treatment of HIV.

KITONSA, J; Komata, R; Ssembajjwe, W; GRINT, D; Robinson, J; RUZAGIRA, E; Kalyesubula, R; Vera, J; CRESSWELL, F;

2026

HIV medicine (2026). 10.1111/hiv.70319.

Knowledge of HIV status in a rural Ugandan population with a sustained, generalised HIV epidemic.

Tomlin, K; Makanga, R; SEELEY, J; SLAYMAKER, E; NEWTON, R; Mugisha, J;

2026

PLOS global public health, (2026).6 10 10.1371/journal.pgph.0007354.

An integrated One Health methodology to study Rift Valley fever, Crimean-Congo haemorrhagic fever and brucellosis at the human-livestock-wildlife interface in Uganda.

Kizito, D; Tweed, S; Mutyaba, J; Babi, N; Lule, SA; Kiggundu, GN; Gibb, R; Nassuna, CA; Ogwal, RS; Paul, E; Haumba, M; Agaba, C; Katushabe, P; Enyel, EM; Balinandi, S; Franklinos, L; Fuller, N; Owen, L; Ringwaldt, E; Ferguson, L; Ndumu, DB; Sekamatte, M; Atimnedi, P; Nyakarahuka, L; Kalema-Zikusoka, G; ... COHRIE-Uganda Team,

2026

One health, (2026).23, 10.1016/j.onehlt.2026.101576.

Adaptation and Validation of Brief Tablet-Based Cognitive Assessment Tool in Uganda.

Valdespino, R; Hromas, G; Wang, C-P; Paul, R; Nakasujja, N; Reynolds, Z; Atwiine, F; Tindimwebwa, E; Greene, M; Passell, E; Ritchie, CS; Hoeppner, SS; Tsai, AC; SEELEY, J; Werry, A; Varfaj, E; Seshadri, S; Okello, S; Asiimwe, S; Saylor, D; Possin, KL; Tsoy, E; Siedner, MJ; Tanner, JA;

2026

medRxiv (2026). 10.64898/2026.09.21.26363152.

Ethical considerations and the social context of HIV phylogenetic research in uMkhanyakude district, KwaZulu-Natal, South Africa.

Chimukuche, RS; Zuma, T; Shandu, Q; Luthuli, M; Gumede, D; SEELEY, J;

2026

Southern African journal of HIV medicine, (2026).27 1 10.4102/sajhivmed.v27i1.1826.

Understanding Adolescent Anti-Retroviral Therapy Use in the BREATHER-Plus Trial: Qualitative Findings From South Africa and Uganda.

Shandu, L; Namukwaya, S; Seunanden, TC; Ngwenya, N; Archary, M; Kityo, C; Ford, D; Pett, SL; Kekitiinwa, AR; Bernays, S; SEELEY, J; BREATHER‐Plus trial team,;

2026

Journal of the International AIDS Society, (2026).29 9 10.1002/jia2.70207.

Effect of a Peer Support Intervention for Oral Pre-Exposure Prophylaxis Uptake and Adherence Among Adolescent Girls and Young Women at Risk of HIV Acquisition in Kampala, Uganda: A Randomized Controlled Trial.

MAYANJA, Y; ABAASA, A; KATUMBA, KR; Spinelli, M; Kikaire, B; Gandhi, M; Kosidou, K; Ekstrom, AM; RUZAGIRA, E;

2026

J Int AIDS Soc, (2026).29 9 10.1002/jia2.70210.

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

Bwakura-Dangarembizi, M; Chappell, E; Kityo, C; Anena, DL; Kiilu, C; Archary, M; Jafta, L; Mujuru, HA; Nakabuye, S; Akabwai, GP; Siika, A; Mngqibisa, R; Mugerwa, H; Walker, S; SEELEY, J; Burger, D; Omar, A; South, A; Nguyen, H; Giaquinto, C; Spittle, B; Bamford, A; Kekitiinwa, AR; Ford, D; Pett, S; ... LATA trial team,

2026

The Lancet, (2026).408 10563 10.1016/S0140-6736(26)01537-0.